Active silver nanoparticles for wound healing

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 4817-4840

  Rigo, Chiara ^a   Ferroni, Letizia ^b   Tocco, Ilaria ^c   Roman, Marco ^a   Munivrana, Ivan ^c   Gardin, Chiara ^b   Cairns, Warren R L ^a   Vindigni, Vincenzo ^c   Azzena, Bruno ^c   Barbante, Carlo ^a   Zavan, Barbara ^b  

^a CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Acticoat 0; Cytotoxicity; Flex 3; ICP MS; In vitro; In vivo; Mitochondrial toxicity; Nanoparticles; SEM; Silver; TEM

Indexed keywords

SILVER NANOPARTICLE;

ARTICLE; BURN; CELL AGGREGATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CONVALESCENCE; CYTOPLASM; DEVICE SAFETY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; SKIN BIOPSY; SKIN PENETRATION; SKIN SURFACE; TRANSMISSION ELECTRON MICROSCOPY; WOUND DRESSING; WOUND HEALING;

EID: 84875075849     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14034817     Document Type: Article

References (62)

1. Klasen, H.J. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000, 26, 117-130.
2. Klasen, H.J. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000, 26, 131-138.
3. Hussain, S.; Ferguson, C. Best evidence topic report. Silver sulphadiazine cream in burns. Emerg. Med. J. 2006, 23, 929-932.
4. Castellano, J.J.; Shafii, S.M.; Ko, F.; Donate, G.; Wright, T.E.; Mannari, R.J.; Payne, W.G.; Smith, D.J.; Robson, M.C. Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int. Wound. J. 2007, 4, 114-122.
5. Ip, M.; Lui, S.L.; Poon, V.K.M.; Lung, I.; Burd, A. Antimicrobial activities of silver dressings: An in vitro comparison. J. Med. Microbiol. 2006, 55, 59-63.
6. Melayie, A.; Youngs, J.W. Silver and its application on antimicrobial agents. Expert. Opin. Ther. Pat. 2005, 15, 125-130.
7. Silvestry-Rodriguez, N.; Sicairos-Ruelas, E.E.; Gerba, C.P.; Bright, K.R. Silver as disinfectant. Rev. Environ. Contam. T. 2007, 191, 23-45.
8. Atiyeh, B.S.; Costagliola, M.; Hayek, S.N.; Dibo, S.A. Effect of silver on burn wound infection control and healing: Review of the literature. Burns 2007, 33, 139-148.
9. Neal, A.L. What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles? Ecotoxicology 2008, 17, 362-371.
10. Okan, D.; Woo, K.; Sibbald, R.G. So what if you are blue? Oral colloidal silver and argyria are out: safe dressings are in. Adv. Skin. Wound. Care 2007, 20, 326-330.
11. Cutting, K.; White, R.; Edmonds, M. The safety and efficacy of dressings with silver-Addressing clinical concerns. Int. Wound. J. 2007, 4, 177-184.
12. Burd, A.; Kwok, C.H.; Hung, S.C.; Chan, H.S.; Gu, H.; Lam, W.K.; Huang, L. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair. Regen. 2007, 15, 94-104.
13. le Duc, Q.; Breetveld, M.; Middelkoop, E.; Scheper, R.J.; Ulrich, M.M.W.; Gibbs, S. A cytotoxic analysis of antiseptic medication on skin substitutes and autograft. Brit. J. Dermatol. 2007, 157, 33-40.
14. Fong, J.; Wood, F. Nanocrystalline silver dressings in wound management: A review. Int. J. Nanomed. 2006, 1, 441-449.
15. Nair, L.S.; Laurencin, C.T. Silver nanoparticles: Synthesis and therapeutic applications. J. Biomed. Nanotechnol. 2007, 3, 301-316.
16. Galdiero, S.; Falanga, A.; Vitiello, M.; Cantisani, M.; Marra, V.; Galdiero, M. Silver nanoparticles as potential antiviral agents. Molecules 2011, 16, 8894-8918.
17. Rai, M.K.; Deshmukh, S.D.; Ingle, A.P.; Gade, A.K. Silver nanoparticles: The powerful nanoweapon against multidrug-resistant bacteria. J. Appl. Microbiol. 2012, 112, 841-852.
18. Chaloupka, K.; Malam, Y.; Seifalian, A.M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010, 28, 580-588.
19. Wilkinson, L.J.; White, R.J.; Chipman, J.K. Silver and nanoparticles of silver in wound dressings: A review of efficacy and safety. J. Wound Care 2011, 20, 543-549.
20. Khundkar, R.; Malic, C.; Burge, T. Use of ActicoatTM dressing in burns: What is the evidence? Burns 2010, 36, 751-758.
21. Wang, X.Q.; Kravchuk, O.; Kimble, R.M. A retrospective review of burn dressings on a porcine burn model. Burns 2010, 36, 680-687.
22. Vlachou, E.; Chipp, E.; Shale, E.; Wilson, Y.T.; Papini, R.; Moiemen, N.S. The safety of nanocrystalline silver dressings on burns: A study of systemic silver absorption. Burns 2007, 33, 979-985.
23. Moiemen, N.S.; Shale, E.; Drysdale, K.J.; Smith, G.; Wilson, Y.T.; Papini, R. Acticoat dressings and major burns: Systemic silver absorption. Burns 2011, 37, 27-35.
24. Trop, M.; Novak, M.; Rodl, S.; Hellbom, B.; Kroell, W.; Goessler, W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J. Trauma 2006, 60, 648-652.
25. Poon, V.K.M.; Burd, A. In vitro cytotoxity of silver: Implication for clinical wound care. Burns 2004, 30, 140-147.
26. Zanette, C.; Pelin, M.; Crosera, M.; Adami, G.; Bovenzi, M.; Larese, F.F.; Florio, C. Silver nanoparticles exert a long-lasting antiproliferative effect on human keratinocyte HaCaT cell line. Toxicol. In Vitro 2011, 25, 1053-1060.
27. Foldbjerg, R.; Dang, D.A.; Autrup, H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch. Toxicol. 2011, 85, 743-750.
28. AshaRani, P.V.; Low Kah Mun, G.; Hande, M.P.; Valiyaveettil, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3, 279-290.
29. Foldbjerg, R.; Olesen, P.; Hougaard, M.; Dang, D.A.; Hoffmann, H.J.; Autrup, H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol. Lett. 2009, 190, 156-162.
30. Hsin, Y.H.; Chena, C.F.; Huang, S.; Shih, T.S.; Lai, P.S.; Chueh, P.J. The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 2008, 179, 130-139.
31. Carlson, C.; Hussain, S.M.; Schrand, A.M.; Braydich-Stolle, L.K.; Hess, K.L.; Jones, R.L.; Schlager, J.J. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112, 13608-13619.
32. Hackenberg, S.; Scherzed, A.; Kessler, M.; Hummel, S.; Technau, A.; Froelich, K.; Ginzkey, C.; Koehler, C.; Hagen, R.; Kleinsasser, N. Silver nanoparticles: Evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett. 2011, 201, 27-33.
33. Labouta, H.I.; Schneider, M. Interaction of inorganic nanoparticles with the skin barrier: Current status and critical review. Nanomed. Nanotechnol. 2013, 9, 39-54.
34. Dunn, K.; Edwards-Jones, V. The role of Acticoat™ with nanocrystalline silver in the management of burns. Burns 2004, 30, S1-S9.
35. Nadworny, P.L.; Landry, B.K.; Wang, J.; Tredget, E.E.; Burrell, R.E. Does nanocrystalline silver have a transferable effect? Wound Repair Regen. 2010, 18, 254-265.
36. Burrell, R.E.; Morris, L.R. Antimicrobial Coating for Medical Device. U.S. Patent 5,753,251, 19 May 1998.
37. Kempf, M.; Kimble, R.M.; Cuttle, L. Cytotoxicity testing of burn wound dressings, ointments and creams: A method using polycarbonate cell culture inserts on a cell culture system. Burns 2011, 37, 994-1000.
38. Du Toit, D.F.; Page, B.J. An in vitro evaluation of the cell toxicity of honey and silver dressings. J. Wound Care 2009, 18, 383-389.
39. Uygur, F.; Oncül, O.; Evinç, R.; Diktas, H.; Acar, A.; Ulkür, E. Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats. Burns 2009, 35, 270-273.
40. Wright, J.B.; Lam, K.; Buret, A.G.; Olson, M.E.; Burrell, R.E. Early healing events in a porcine model of contaminated wounds: Effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002, 10, 141-151.
41. Huang, Y.; Li, X.; Liao, Z.; Zhang, G.; Liu, Q.; Tang, J.; Peng, Y.; Liu, X.; Luo, Q. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 2007, 33, 161-166.
42. Tonello, C.; Zavan, B.; Cortivo, R.; Brun, P.; Panfilo, S.; Abatangelo, G. In vitro reconstruction of human dermal equivalent enriched with endothelial cells. Biomaterials 2003, 24, 1205-1211.
43. Tonello, C.; Vindigni, V.; Zavan, B.; Abatangelo, S.; Abatangelo, G.; Brun, P. Cortivo, R. In vitro reconstruction of an endothelialized skin substitute provided with a microcapillary network using biopolymer scaffolds. FASEB J. 2005, 19, 1546-1548.
44. Rigo, C.; Roman, M.; Munivrana, I.; Vindigni, V.; Azzena, B.; Barbante, C.; Cairns, W.R.L. Characterization and evaluation of silver release from four different dressings used in burns care. Burns 2012, 38, 1131-1142.
45. Thaler, A.; Heidari, N.; Cox, B.G.; Schneider, H. Stability constants of copper(I) and silver(I) complexes with open-chain, macrocyclic and -bicyclic aza-ligands in acetonitrile and comparison with results in dimethylsulfoxide. Inorg. Chim. Acta 1999, 286, 160-168.
46. Gravante, G.; Montone, A. A retrospective analysis of ambulatory burn patients: focus on wound dressings and healing times. Ann. R. Coll. Surg. Engl. 2010, 92, 118-123.
47. Xu, R.X. Physiological Healing Procedure and Histological Observation on Deep Second-Degree Burns Treated with MEBO. In Burns Regenerative Medicine and Therapy; Sun, X., Ed.; Karger: Basel, Switzerland, 2004; pp. 106-111.
48. Kim, S.; Choi, J.E.; Choi, J.; Chung, K.H.; Park, K.; Yi, J.; Ryu, D.Y. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. In Vitro 2009, 23, 1076-1084.
49. Greulich, C.; Diendorf, J.; Simon, T.; Eggeler, G.; Epple, M.; Koeller, M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011, 7, 347-354.
50. Hirokawa, N.; Bloom, G.S.; Vallee, R.B. Cytoskeletal architecture and immunocytochemical localization of microtubule-associated proteins in regions of axons associated with rapid axonal transport: The β,β'-iminodipropionitrile-intoxicated axon as a model system. J. Cell. Biol. 1985, 101, 227-239.
51. Ball, E.H.; Singer, S. Mitochondria are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Prod. Natl. Acad. Sci. USA 1982, 79, 123-126.
52. Lee, H.C.; Yin, P.H.; Lu, C.Y.; Chi, C.W.; Wei, Y.H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 2000, 348, 425-432.
53. Marchi, S.; Giorgi, C.; Suski, J.M.; Agnoletto, C.; Bononi, A.; Bonora, M.; de Marchi, E.; Missiroli, S.; Patergnani, S.; Poletti, F., et al. Mitochondria-ros crosstalk in the control of cell death and aging. J. Signal. Transduct. 2012, 2012, doi:10.1155/2012/329635.
54. Kim, H.R.; Kim, M.J.; Lee, S.Y.; Oh, S.M.; Chung, K.H. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat. Res. Gen. Tox. En. 2011, 726, 129-135.
55. Ciriolo, M.R.; Civitareale, P.; Carri, M.; De Martino, A.; Galiazzo, F.; Rotilio, G. Purification and characterization of Ag, Zn-superoxide dismutase from Saccharomyces cerevisiae exposed to silver. J. Biol. Chem. 1994, 269, 25783-25787.
56. Lansdown, A.B.G. Silver in health care: Antimicrobial effects and safety in use. Curr. Probl. Dermatol. 2006, 33, 17-34.
57. Cuttle, L.; Naidu, S.; Mill, J.; Hoskins, W.; Das, K.; Kimble, R.M. A retrospective cohort study of Acticoat™ versus Silvazine™ in a paediatric population. Burns 2007, 33, 701-707.
58. Marazzi, M.; de Angelis, A.; Ravizza, A.; Ordanini, M.N.; Falcone, L.; Chiaratti, A.; Crovato, F.; Calò, D.; Veronese, S.; Rapisarda, V. Successful management of deep facial burns in a patient with extensive third-degree burns: The role of a nanocrystalline silver dressing in facilitating resurfacing. Int. Wound J. 2007, 4, 8-14.
59. Strand, O.; San Miguel, L.; Rowan, S.; Sahlqvist, A. Retrospective comparison of two years in a paediatric burns unit, with and without acticoat as a standard dressing. Ann. Burns Fire Disasters 2010, 23, 182-185.
60. Rheinwald, J.G.; Green, H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 1975, 6, 331-343.
61. Brun, P.; Cortivo, R.; Zavan, B.; Vecchiato, N.; Abatangelo, G. In vitro reconstructed tissues on hyaluronan-based temporary scaffolding. J. Mater. Sci. Mater. M. 1999, 10, 683-688.
62. Denizot, F.; Lang, R. Rapid colorimetric assay for cell-growth and survival-Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89, 271-277.